1993
DOI: 10.1016/0026-0495(93)90098-9
|View full text |Cite
|
Sign up to set email alerts
|

The effects of changes in plasma nonesterified fatty acid levels on oxidative metabolism during moderate exercise in patients with non-insulin-dependent diabetes mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1997
1997
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…1991, Akanji et al. 1993); in one study, growth hormone concentrations were seen to rise considerably with acipimox, perhaps reflecting the inhibitory feedback of NEFA on the hypothalamus (Akanji et al. 1993).…”
Section: Current Views: Delivery Of Fatty Acids In Relation To Musculmentioning
confidence: 99%
See 1 more Smart Citation
“…1991, Akanji et al. 1993); in one study, growth hormone concentrations were seen to rise considerably with acipimox, perhaps reflecting the inhibitory feedback of NEFA on the hypothalamus (Akanji et al. 1993).…”
Section: Current Views: Delivery Of Fatty Acids In Relation To Musculmentioning
confidence: 99%
“…Typically, with suppression of lipolysis, oxidation of carbohydrate and of fat from other sources increases (Walker et al. 1991, Akanji et al. 1993); in one study, growth hormone concentrations were seen to rise considerably with acipimox, perhaps reflecting the inhibitory feedback of NEFA on the hypothalamus (Akanji et al.…”
Section: Current Views: Delivery Of Fatty Acids In Relation To Musculmentioning
confidence: 99%
“…Two methods were used to modify NEFA levels: intravenous heparin (which releases lipoprotein lipase from the capillary endothelium, resulting in increased hydrolysis of circulating lipoprotein triglycerides) was used to raise NEFA levels and acipimox (an analogue of nicotinic acid which inhibits adipose tissue lipolysis) was used to lower plasma NEFA levels. Similar strategies to modulate circulating NEFA levels were used in previous studies [13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Greater levels of plasma FFA prevent glucose uptake by muscle [30, 31] and could therefore explain the increase in blood glucose levels in the INS trial. In support of this suggestion, reductions in plasma FFA through treatment with acipimox have been shown to decrease fat oxidation, increase carbohydrate oxidation, and lower blood glucose during moderate intensity exercise in T2D patients [32]. Patients with T2D have impaired ability to oxidize muscle glycogen during exercise [19], and the lower plasma glucose availability in the INS trial perhaps explains the greater increase in FFA in that trial.…”
Section: Discussionmentioning
confidence: 99%